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Abstract 
 
While coping varies with individuals and is a product of complex, interrelated factors, the 
primary interest of this study was determining how coping behaviors manifest according 
to these chronic illness types: those of known pathology (e.g., asthma, osteoarthritis, 
lupus) and those that lack a clear, structural pathology (i.e., functional somatic syndromes 
and medically unexplained symptoms). Data for this study were gathered from a series of 
four comprehensive online surveys, which included measures of coping (Brief COPE), 
pain and health outcomes (SF-36), negative affect (I-PANAS-SF) and depression (PHQ-
8). The analyzed sample was comprised of 148 participants (119 Female, 28 Male and 1 
Not Answered) with a mean age of 43.34 (SD = 13.69), all of whom experienced at least 
three months of chronic physical symptoms. Based on diagnosis, the participants were 
grouped into that of conventional disease (CD), functional somatic syndromes (FSS) or 
medically unexplained symptoms (MUS). Even while controlling for significant 
covariates (e.g., depression, negative affect, pain perception), multivariate analyses 
revealed no significant differences in coping strategies by illness group, Wilks’s Lambda 
= .96, F(4, 222) = 1.05, p = .38.  
The results suggest that the use of coping strategies does not differ by illness type, 
but can be predicted by other, health-related factors, notably stress, β = -.21, t(120) =        
-2.09, p = .04;  symptoms, β = .32, t(120) = 2.82, p = .01; personal control, β = .19, t(120) 
= 2.16, p = .03, and negative affect, β = .34, t(121) = 2.81, p = .01. It appears that patient 
experience with chronic illness can be more informative regarding appropriate treatments 
and therapeutic interventions than just illness type itself. 
 
Coping with Chronic Illness: Do Strategies Differ by Illness Type? 
According to recent estimates, chronic illnesses are widely prevalent; in 2005, a 
reported 133 million Americans, or nearly 1 out of every 2 adults had at least one chronic 
illness (Centers for Disease Control, 2010; Kung, Hoyert, Xu, & Murphy, 2008). The 
leading cause of death and disability, chronic illness is distressing and costly, purportedly 
costing the U.S. economy more than $1 trillion annually, a figure that represents both the 
explicit costs of health care as well as the indirect costs of productivity losses (Centers 
for Disease Control, 2010; DeVol, Bedroussian, & Charuworn, 2007). Due to the 
sustained nature of chronic illnesses and their pervasive, potentially severe impact, it is 
necessary to identify ways in which illnesses can be effectively prevented, treated or 
managed. This requires articulation of the possible factors at work in the etiopathogenesis 
and perpetuation of certain chronic illness experiences, particularly those that lack 
distinct, uniformly presenting and universally accepted diagnostic criteria, those that 
occur at the interface of pathophysiology and psychopathology (Henningsen, Zipfel, & 
Herzog, 2007; McFarlane, Ellis, Barton, Browne, & Van Hooff, 2008). Coping, integral 
to illness and symptom management, is a function of these multiple interacting factors as 
they affect cognitive appraisal, behavioral response and adjustment. Determining whether 
different coping patterns are associated with certain illness experiences can provide 
useful information regarding illness treatment and patient outcomes.    
Stress and Coping 
Living with chronic illness requires the ability to adapt to living with the stressors 
of unremitting symptoms, such as pain, fatigue, depression and anxiety. While recovery 
is the desired outcome of illness, for those with chronic illnesses, the more attainable 
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outcome may be that of maintained psychological and physiological well-being in the 
face of these chronic demands on fitness, a process of “stability through change” known 
as allostasis (McEwen, 2007; Sterling, 2004; Sterling & Eyer, 1988 in Stewart et al., 
1989).  The use of effective coping strategies, mechanisms by which people respond to 
and manage stress, is essential to achieving this adaptive dynamic, particularly when 
illness course and outcomes are uncertain (Cairns & Hotopf, 2005; Carver, Scheier & 
Weintraub, 1989; Lazarus & Folkman, 1984).    
Appraisal. The transactional model of stress and coping by Lazarus and Folkman 
(1984) regards coping as a function of stress appraisal; stress is defined in their model as 
perceived threats to well-being or of demands that are perceived to be taxing of 
individual internal and/or external resources (Folkman & Moskowitz, 2004; Lazarus & 
Folkman, 1984). Essential to their model is the idea that stress and coping is a transaction 
mediated by the person’s appraisal of both the perceived threat and the perceived 
resources available to respond to the threat (Carver et al., 1989; Lazarus & Folkman, 
1984; Glanz, Rimer, & Lewis, 2002, p.215).  As a result, coping is a highly perceptually-
driven process that yields strategies befitting individual needs across a variety of 
situations (Carver et al., 1989; Lazarus & Folkman, 1984; Schreurs & de Ridder, 1997; 
Walker, Jackson, & Littlejohn, 2004).  
Coping response. Stressors provoke coping responses that fall into two general 
categories: problem-focused coping, which involves directing action to resolve or alter 
the threat and emotion-focused coping, which involves management of the emotions 
elicited by the threat (Carver et al., 1989; Folkman & Lazarus, 1980). Problem-focused 
coping is oriented to approaching the source of stress, encompassing coping strategies 
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such as planning, problem-solving, restraint, seeking information/instrumental advice and 
cognitive reappraisal (Carver et al., 1989; Feder, Nestler, Westphal, & Charney, 2010; 
Thoits, 1995). Emotion-focused coping is managing and/or mitigating problematic 
emotional responses to stress, such as fear and distress, by using strategies like 
avoidance, denial, venting, disengagement, acceptance, positive reappraisal and 
emotional support (Carver et al., 1989; Thoits, 1995). Typically, people employ both 
forms of coping to some degree when managing stress, adjusting their strategies as 
context and individual preferences dictate (Folkman & Lazarus, 1980).    
 Stress regulation and neural correlates. Stress appraisal and coping responses 
are largely associated with the construct of executive functioning, the interrelated and 
effortful cognitive processes involved in attention, perception, problem solving, 
strategizing, task-switching, emotion regulation and behavioral modification (Hall, 
Crossley, & D’Arcy, 2010; Nes, Roach, & Segerstrom, 2009; Williams, Suchy, & Rau, 
2009; Williams & Thayer, 2009). Regardless of the type or combination of strategies 
used, all coping requires executive function to exert self-control over cognitive, 
emotional, and behavioral responses to stress (Nes et al., 2009). The process of conscious 
cognitive self-management, or self-regulation, is particularly important as it can direct 
stress appraisal and reactivity (Maes & Karoly, 2005; Williams et al., 2009; Williams & 
Thayer, 2009).  While self-regulation is the act of self-management, the perception of 
capability or effective performance is typically regarded as self-efficacy; this theoretical 
concept, interwoven with factors like attribution, motivation and expectation, influences 
coping strategy selection  (Bandura, 1997 in Glanz et al., 2002, p.215; Deary, Chalder, & 
Sharpe, 2007). For example, an individual that perceives greater controllability or sense
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of mastery regarding a stressor is more likely to use the more active problem-focused and 
emotion-focused coping strategies, like problem solving and positive reappraisal; 
conversely, one that perceives less controllability is more likely to use the more passive 
and avoidant coping strategies, like avoidance, denial and escapism, as the stressor is 
seen as something not able to be changed, but ‘endured’ (Carver et al., 1989; Folkman & 
Lazarus, 1980; Thoits, 1995).  
Findings from brain imaging and behavioral studies of those with frontal lobe 
damage suggest that executive functions are orchestrated by the prefrontal cortex (PFC) 
and connections along the frontoparietal network (Nes et al., 2009; Williams et al., 2009; 
Williams & Thayer, 2009). Associated brain structures are the amygdala, thalamus and 
hippocampus, structures that feature in the limbic system, which is implicated in memory 
and top-down regulatory processing (Nes et al., 2009; Williams et al., 2009; Williams & 
Thayer, 2009). Damage to the PFC is associated with poorer executive functioning, 
which can manifest as disinhibition, perseveration, inflexibility, organizational and 
attention deficits and impairments in task switching and problem solving (Nes et al., 
2009; Rossi, Pessoa, Desimone, & Ungerleider, 2009; Williams et al, 2009). Factors that 
inhibit or disrupt the executive operations of the brain, such as lesions to the PFC, 
dysfunctional network communication with components of the brainstem (which feature 
in arousal and evolutionarily-wired, autonomic responses) or other functional 
neuroconnectivity and processing issues, can negatively influence or interfere with the 
cognitive operations of the stress response (Sterling, 2004; Williams et al., 2009; 
Williams & Thayer, 2009).                                                                                                       
 Stress regulation in chronic illness. Chronic illness poses a significant challenge 
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to successful coping because chronic illness induces stress on an already vulnerable 
individual; the demands of illness compounded by the accumulative effects of stress may 
impose severe limitations on a sufferer’s ability to self-regulate to manage stress 
(Heijmans et al., 2004). There is empirical evidence that self-regulatory ability is subject 
to fatigue and that as an internal resource, it is subject to limits that vary among 
individuals and can be depleted (Nes et al., 2009; Williams & Thayer, 2009). Stressors 
can drain self-regulatory strength, inhibiting perceptual-sensitive processes like coping.  
 As it appears that it is a person’s subjective experience with stressors that yields 
variability of coping response, alterations in the perceptual process of stress appraisal 
could make illness symptoms and stressors virtually ‘intolerable’ as sensations are 
amplified and tolerance is reduced (Bombardier, D'Amico, & Jordan, 1990; Leventhal et 
al., 1997; Maes et al., 1996 in Heijmans et al., 2004; Heijmans et al., 2004; Tak & 
Rosmalen, 2010; Van Houdenhove, Van Den Eede, & Luyten, 2009; Yunus, 2007). 
Research on pain, a common symptom and stressor in chronic illness, illustrates that 
intensity of sensation can be modulated by emotional regulation and cognitive processes, 
like attention and expectation (Wiech, Ploner, & Tracey, 2008).  In addition to 
amplifying symptom perception, perceptual alterations associated with chronic stress can 
exaggerate the sensations of peripheral, irrelevant stimuli, interfering with healthy 
functioning as threat perception and hyper-reflection or hypervigilance for threats 
increase (Deary et al., 2007). This cognitive bias to detect negative or fear-related stimuli, 
in conjunction with enhanced bodily sensitization, sustains arousal and stress activation 
(Deary et al., 2007). As the attentional system is automatically oriented to threats, 
hypervigilance for threats can restrict available cognitive resources required for 
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information processing and self-regulation (Putman & Roelofs, 2011; Ursin, 2005 in 
Deary et al., 2007). 
A Model of Stress Dysregulation 
Chronic activation of the stress response. The stress of chronic illness can 
heighten threat detection and initiate greater stress reactivity, prompting repeated 
mobilization of physiological and psychological responses. Stress triggers cascades of 
neuroendocrine effectors, such as the secretion of hypothalamic corticotrophin-releasing 
hormone (CRH) and arginine vasopressin, as well as the glucocorticoid cortisol by the 
adrenal gland and the brainstem-derived catecholamines norepinephrine and epinephrine. 
These effectors activate the “fight-or-flight” response of the sympathetic nervous system 
(e.g.,  increased arousal, accelerated heart and metabolic rate, suppression of the “rest and 
digest” activities of the parasympathetic nervous system) and executive application of 
coping mechanisms, mediated by activation of the hippocampus and amygdala, to 
address the source of stress or to manage arousal and distress (Chrousos, 2009; 
McFarlane et al., 2008; Nes et al, 2009; Olff, Langeland, & Gersons, 2005; Williams et 
al., 2009; Williams & Thayer, 1999).The framework behind allostatic load suggests that 
repeated stress response activation leads to greater “wear and tear”  of the stress system, 
which is characterized by physiological indices of stress dysregulation or dysfunctional 
operation of the processes of the neuroendocrine and immune systems (Feder et al., 2010; 
Glei, Goldman, Chuang, & Weinstein, 2007). The hypothalamic-pituitary-axis (HPA) 
axis of the PFC, the locus ceruleus-norepinephrine (LC-NE) system, the mood-associated 
serotonergic system, and the reward-mechanisms of the dopaminergic system are 
neurobiological components of the stress system; dysregulation of one or more of these 
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components, reflected in hypo or hyperactivity of neuroendocrine effector secretion, 
suggests malfunctioning of the stress system (Feder et al., 2010; Haglund, Nestadt, 
Cooper, Southwick, & Charney, 2007; Van Houdenhove et al., 2009).  
A dysregulated system. An implication of dysregulation is that once arrived, it 
persists. As stressors trigger inadequate or inappropriate stress responses, executive 
functions necessary to self-regulate and “override” are impaired by the neurobiological 
effects of dysregulation, thus maintaining, or even intensifying, the cycle of stress system 
dysfunction (Chrousos, 2009; Van Houdenhove & Luyten, 2008; Van Houdenhove et al., 
2009).  Irregular activity of the stress system is associated with structural changes in the 
hippocampus and amygdala; changes in these memory and emotion-associated structures 
are implicated in maladaptive executive functions, like hypervigilance and rumination 
(McEwen & Milner, 2007 in Feder et al., 2010). Hori et al. (2010) tested the relationship 
between irregular stress activity and executive functions in 121 healthy adults, dividing 
them into three groups based on their cortisol secretion suppression pattern (blunted or 
suppressed patterns are indices for stress system irregularities). According to self-report 
of psychological distress and coping styles, in comparison to the other groups, the 
enhanced suppressors of cortisol reported higher levels of anxiety, obsessive-
compulsiveness and greater uses of avoidant coping strategies (Hori et al., 2010). While 
this study was conducted with non-clinical adults with differing cortisol patterns, it shows 
that stress dysregulation is associated with poorer “top-down” executive functioning and 
maladaptive behaviors.                                                                                                       
 Illnesses associated with stress dysregulation.  Functional somatic syndromes 
(FSS), which include fibromyalgia, chronic fatigue syndrome (CFS) and 
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irritable bowel syndrome (IBS), are syndromes that lack a clearly established 
pathophysiology (e.g., tissue damage, structural abnormality) and are characterized by the 
suffering of a constellation of chronic physical symptoms, like muscle aches, nausea, 
palpitations and sleeping difficulties (Barsky & Borus, 1999; Sharpe & Carson, 2001; 
Yunus, 2007). Often, the distinction between FSS and medically unexplained symptoms 
(MUS) is the official diagnosis for FSS by a physician; in some studies, illnesses of 
unknown etiology, like CFS and IBS, are considered MUS because of their biomedically 
“unexplained” nature (Deary et al., 2007; McFarlane et al., 2008). The multiple 
functional somatic syndromes and MUS share considerable overlap of symptoms (e.g., 
many fibromyalgia patients report severe fatigue and many chronic fatigue patients report 
chronic pain); as a result, speculation remains as to whether the many syndromes are 
really just different bodily manifestations of the same underlying disorder (Henningsen et 
al., 2007; Yunus, 2007). Researchers operating from the stress dysregulation hypothesis 
argue that the presence of persistent physical symptoms of unknown etiology, as in FSS 
and MUS, may result from and be perpetuated by stress response abnormalities; there 
may be nominal and diagnostic differences, but the disorders may essentially be the same 
(Chrousos, 2009; Heim, 2009; McFarlane et al., 2008; Van Houdenhove & Egle, 2004; 
Van Houdenhove et al., 2009; Yunus, 2007).  
Because of the frequent comorbidity of depression and/or anxiety with FSS and 
MUS, it was previously hypothesized that FSS/MUS symptom experience resulted from 
somatization or even malingering by the depressed or chronically anxious patient. To 
examine relationships between FSS/MUS, anxiety and depression, Henningsen, 
Zimmermann, and Sattel (2003) conducted a meta-analysis of 244 observational studies, 
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which encompassed 18,690 participants, focusing on comparisons between FSS (i.e., 
irritable bowel syndrome, nonulcer dyspepsia, fibromyalgia and chronic fatigue 
syndrome) and healthy controls (Henningsen et al., 2003). While they found that the 
association between FSS with depression and anxiety was significantly higher than that 
of controls, the studied syndromes were shown to be independent of anxiety and 
depression, dispelling the notion that the somatic symptoms of these syndromes arose 
from depression and anxiety (Henningsen et al., 2003; McFarlane et al., 2008).  
Physiological indices suggestive of stress system dysregulation have been found 
in those with FSS. In several studies, including a meta-analysis of 14 studies on subjects 
with FSS and a population-based study of FSS in 744 adults, lower baseline cardiac vagal 
activity (derived from heart rate variability, a proxy for increased arousal and reduced 
parasympathetic activity) was associated with FSS (Tak & Rosmalen, 2010). There was 
no evidence that this cardiac vagal activity differed significantly among the syndromes of 
chronic fatigue syndrome, fibromyalgia and irritable bowel syndrome (Tak & Rosmalen, 
2010). While these results suggest that there are alterations of the autonomic nervous 
system in those with FSS, other studies suggest a general correlation between FSS and 
irregular HPA axis activity in the central nervous system (McFarlane et al., 2008; Tak & 
Rosmalen, 2010).  Lower cortisol levels and a flattened diurnal rhythm of cortisol (i.e., in 
a diurnal pattern of enhanced suppression: lower levels upon awakening in the morning 
and higher levels in the evening), considered indices of irregular HPA activity, have been 
found in those with chronic fatigue syndrome, fibromyalgia and post-traumatic stress 
disorder (PTSD) (McFarlane et al., 2008; Tak & Rosmalen, 2010). Immunology research 
also suggests a link between deficient HPA axis functioning and neuroimmune 
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activation; chronic activation by release of inflammatory cytokines can induce a systemic 
sickness response that includes symptoms that resemble that of FSS: fatigue, flu-like 
symptoms, mood disturbance, cognitive deficits and hyperalgesia (Chrousos, 2009; Van 
Houdenhove et al., 2009).  
The sickness symptoms experienced by those with FSS and MUS are prevalent in 
the general, non-clinical population. Yet, it is those with FSS and MUS that experience 
these symptoms to a degree that can be disabling (Barsky & Borus, 1999). Through the 
lens of the integrative model of stress system dysregulation, these symptom experiences 
may result from heightened central and peripheral neuronal sensitivity to stimuli 
proposed to manifest from and/or exist concurrently with a complex interaction of 
factors, such as prior trauma, biological predisposition, psychosocial vulnerability and 
lifestyle characteristics, like obesity, medication use or physical inactivity (Tak & 
Rosmalen, 2010; Van Houdenhove & Luyten, 2008; Van Houdenhove et al., 2009; 
Yunus, 2007). While it is not fully clear whether this heightened sensitivity precipitates 
stress dysregulation or if these overlapping “sensitivity” syndromes emerge as products 
of dysregulation, the relationship appears to be bidirectional (Van Houdenhove & 
Luyten, 2008; Yunus, 2007). As regulatory anomalies perpetuate the disease experience, 
amplifying symptoms of pain, fatigue and stress, chronic activation of the stress system 
in response to illness symptoms can yield physiological and maladaptive alterations of 
the stress system (Chrousos, 2009; Henningsen et al., 2007; Nes et al., 2009; Sanders & 
Korf, 2007; Tak & Rosmalen, 2010; Van Houdenhove et al., 2009).  
Impact of Stress Dysregulation on Appraisal and Coping   
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 In the context of chronic illness, coping strategies are not only dependent on how 
illness symptoms and illness consequences are appraised, but emerge from a combined 
influence of factors along with illness, which include age, gender, available resources, 
affect, perceived social support, symptom duration and intensity and perceived impact on 
what the individual values (e.g., employment, romantic relationship, lifestyle; Folkman & 
Moskowitz, 2004; Schreurs & de Ridder, 1997). As a result of this complexity, teasing 
apart whether coping strategies are associated with certain illness experiences 
independent from other relevant factors can be difficult.  
Gender and affect confounds. There is empirical support for coping variation by 
individual differences like gender and negative affect (Carver et al., 1989; Folkman & 
Moskowitz, 2004). Women have reported greater use of active and passive emotion-
focused coping strategies, while negative affect has shown association with greater 
passive strategies like avoidance (Carver et al., 1989; Folkman & Moskowitz, 2004; 
Matud, 2004). This gender distinction is important to consider because of the 
“preponderance” of women reporting the symptoms of FSS and epidemiological data that 
indicate that women report higher rates of depression and pain severity (Henningsen et 
al., 2007; Munce & Stewart, 2007). How gender features in the incidence of FSS, 
whether psychosocially in gender roles as they impact stress appraisal and/or as possible 
neuroendocrine correlates of affective/perceptual differences, is relevant because of the 
tendency for FSS patients to be women (Fantoni et al., 2007; Matud, 2004). 
Still, gender alone does not predict coping, even in FSS and MUS. A study by 
Nater and colleagues (2006) of chronic fatigue symptoms in the general population of 
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Wichita, Kansas evaluated the coping strategies of a sample of 164 men and women in 
which 43 were diagnosed with chronic fatigue syndrome, 61 with chronic unexplained 
fatigue and 60 were healthy controls (Nater et al., 2006). Though the men-to-women ratio 
of the sample was approximately 1:4, each group approximated the same ratio. They 
found that the CFS and chronic unexplained fatigue group did not significantly differ 
from one another, but that both groups used significantly more escape-avoidance 
strategies than controls (Nater et al., 2006). The difference in strategies was not 
associated with gender, but with chronic illness.  
Appraisal and attentional biases. More research findings have emerged to 
suggest that patterns of coping in chronic illnesses could be illness or illness-cluster 
associated, particularly if the illness is stress dysfunction-related. People suffering from 
illnesses characterized by heightened stress-associated perceptual sensitivity, as in FSS 
and MUS, would theoretically be less equipped to tolerate and manage stress, especially 
as internal resources are depleted, allostatic load is reached, and executive functions 
required to self-regulate are inhibited or compromised (Nes et al., 2009; Van 
Houdenhove et al., 2009; Yunus, 2007). Perceptual sensitivity yields a chronically 
reactive stress system as the individual interprets even peripheral, insignificant stimuli as 
stressful or threatening, triggering the neuroendocrine responses that can further sensitize 
the individual (Olff et al., 2005). Olff and colleagues (2005) regard this appraisal process 
as the “crucial first step” that can lead to symptom experience. Furthermore, in their 
review of stress and trauma studies, they determined that “conscious threat perception is 
necessary” for stress dysregulation to occur (Olff et al., 2005).  
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Distress avoidance and regulatory fatigue. The association of FSS and MUS 
with passive coping strategies is well documented, even if the mechanisms of this 
association are not understood (Barsky & Borus, 1999; Nater et al., 2006; Van 
Houdenhove et al., 2009; Zautra, Hamilton, & Burke, 1999). Studies of chronic fatigue 
syndrome, chronic pain conditions (including fibromyalgia, temporomandibular disorder 
and irritable bowel syndrome) illustrate that those with such conditions engage in more 
passive coping strategies, like avoidance, disengagement, inactivity, escapism and 
reliance on external sources for support (Feder et al., 2010; Heim, 2009; Nater et al., 
2006; Nes et al., 2009, Zautra et al., 1999). One consideration for this relationship is that 
FSS and MUS consist of unexplained illnesses with few, if any, treatment options. 
Medication to mitigate symptoms, sensory gating and cognitive-behavioral therapy are 
treatment options that show some promise; however, these are treatments that help 
manage, not eliminate, illness (McFarlane et al., 2008; Van Houdenhove et al., 2009). 
Because of this inherent lack of active strategies in treating these illnesses, it could be 
that the greater reliance on passive coping strategies reflects this lack of available 
options.  
Another consideration is that the passive strategies may arise from impairments 
resulting from illness. In their review of chronic pain studies, Nes and colleagues (2009) 
speculate that those with chronic pain conditions experience self-regulatory fatigue or 
deficits in executive functioning, requiring them to use passive coping strategies as those 
are only ones for which they have enough strength (Nes et al., 2009). Therefore, it is not 
surprising that those suffering from FSS or MUS may exhibit functional limitations in 
coping that would lead them to engage in more passive strategies. 
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While there is nothing inherently maladaptive about passive coping strategies, 
many studies suggest that passive coping strategies, like avoidance and escapism, 
contribute to higher distress levels and poorer outcomes; whereas active coping 
strategies, such as problem-focused strategies and the seeking of social support for 
instrumental reasons, are associated with greater well-being, capacity for stress and 
positive psychological adjustment (Ax, Gregg, & Jones, 2001; Carver et al., 1989; Feder 
et al., 2010; Folkman & Moskowitz, 2004; Hori et al., 2010; McFarlane et al., 2008; 
Pellissier, Dantzer, Canini, Mathieu, & Bonaz, 2010; Taylor & Stanton, 2007; Walker et 
al., 2004; Zautra et al., 1999). Passive coping strategies may be beneficial in the short-
term; for example, mental or behavioral disengagement strategies, like watching TV or 
daydreaming, can distract someone from the demands of a stressor, providing temporary 
relief. However, as passive coping strategies do not directly address the stressor, whether 
through behavioral or cognitive means, over the long term they may just prolong and 
intensify stressful experience (Carver et al., 1989). 
Coping Behaviors by Chronic Illness Groups 
 The purpose of this study was to examine the coping behaviors of those with 
chronic illnesses of known and unknown structural pathology. Illnesses were grouped by 
illness pathology type into that of “conventional disease” (CD), FSS or MUS. Predictions 
of coping behaviors of these groups, particularly the FSS and MUS groups, were based 
on the model of stress system dysregulation and how dysregulation is postulated to affect 
stress appraisal and coping response. The CD group served as a reference group.  
Hypotheses. In terms of appraisal, when compared to the CD group, it was 
expected that the FSS and MUS groups would report higher levels of symptom 
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experience, intensity and severity, higher levels of stress and more serious consequences 
of their illnesses. The FSS group was also expected to report more negative appraisals 
(e.g., more symptom distress, more negative feelings) than the MUS group. Perceived 
controllability and coping strategies, as categorized by active or passive/avoidant, were 
expected to differ between the CD and the FSS/MUS groups. Those in the FSS and MUS 
groups were expected to report greater use of passive/avoidant coping strategies.  
Method 
Data were collected from participant responses to a series of four comprehensive 
online surveys designed to capture chronic illness experiences. Collectively known as the 
VOICE (Verification of Illness, Coping and Experience) study, the surveys examined 
four different aspects of illness experience: personal views of physical symptoms; coping 
with symptoms; relationships and support; and impact of illness. The surveys were open 
to all consenting adults that reported at least three months of recurrent physical 
symptoms. The final data used for analysis excluded participants with primary diagnoses 
of psychiatric or affective disorders (e.g., depression, generalized anxiety disorder, 
somatization disorder) and participants that did not complete all four surveys.    
Participants 
 Illnesses and group categorization. Participants fulfilling the study criteria 
represented 45 different chronic illness and symptom conditions (see Table 1 and Table 2 
for more details). Reflective of this breadth, 29 participants alone represented 29 different 
illnesses.  Of them all, fibromyalgia (N = 36) was the most frequently reported (see 
Figure 1 for the top 5 diagnoses). Based on categorizations found in the literature 
(Henningen et al., 2007; Yunus, 2007), medical convention and diagnostic criteria 
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reported by the Centers for Disease Control (2010), illnesses were assigned to one of 
three illness groups: conventional disease (CD), functional somatic syndrome (FSS) or 
medically unexplained symptoms (MUS). Illnesses characterized by distinct structural 
pathology and etiology as well as established criteria formed the CD group. Illnesses 
characterized by indistinct or unknown structural pathology and etiology as well as 
emerging and/or conflicting diagnostic criteria formed the FSS group. Patients that 
reported no diagnosis for their symptoms and/or selected the diagnosis of “Medically 
Unexplained Symptoms” in the surveys formed the MUS group (N = 23). While not a 
traditional control group, the intent for this study was for the CD group to serve as a 
comparison group of those with “typical”, medically accepted, chronic diseases.  
 
 
Table 1. Conventional Diseases 
Illness Name Count Illness Name Count 
Allergic Rhinitis 1 Graves’ Disease 1 
Asthma 1 High Blood Pressure 1 
Celiac Disease 1 Hypothyroidism 1 
Chiari Malformation Type 1 1 Interstitial Cystitis 1 
COPDa 1 Lyme Disease 1 
Chronic Tonsilitis 1 Post-Polio Syndrome 1 
CREST Limited Scleroderma 1 Pudendal Nerve Entrapment 2 
Crohn’s Disease 1 Rheumatoid Arthritis 3 
Degenerative Disc Disease 1 Sarcoidosis 6 
Diabetes 2 Shingles 1 
Dysautonomia 1 Sphincter of Oddi Dysfunction 1 
Eczema 1 Spondylitis 1 
Ehlers Danlos Syndrome 2 Stiff Person Syndrome 1 
Endometriosis 1 Systemic Lupus Erythematosus 1 
aChronic Obstructive Pulmonary Disease 
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                              Table 2. Functional Somatic Syndromes 
Illness Name Count 
Atypical Facial Pain 1 
Chronic Fatigue Syndrome/CFIDS 12 
Chronic Low Back Pain 3 
Chronic Pain 1 
Fibromyalgia 36 
Insomnia 1 
Irritable Bowel Syndrome 3 
Morgellons Disease 2 
Multiple Chemical Sensitivity 2 
Myofascial Pain Syndrome 1 
Pseudoseizures 1 
Restless Legs Syndrome 12 
Sick Building Syndrome 1 
Temporomandibular Joint Disorder 3 
 
 
 
 
 
Figure 1. Top 5 Diagnoses of Participants 
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Demographics. The sample consisted of 148 participants (119 female, 28 male 
and 1 not answered). The mean age of participants was 43.34 (SD = 13.69) and 85.80% 
of participants reported experiencing symptoms for over one year. While the groups were 
not evenly divided (greatest amount was in the FSS group), their demographic 
characteristics were similar. Affirming the similarities, cross tabulations using chi-square 
tests showed no significant differences by group at the .05 level. See Tables 3 and 4 for 
further details on the sample and group demographics.  
        Table 3. Sample Demographics 
Number of Participants 148  
Gender 119 Female, 28 Male, 1 Not Answered 
Mean Age 43.34 (SD = 13.69) 
Illness Chronicity 85.8% symptoms for over 1 year   
Annual Income 49.0% in $20,000 - $50,000 bracket 
Relationship Status 68.9% in a relationship/married/cohabitating 
Race/Ethnicity 91.2% White/Caucasian 
 
Table 4. Demographics by Illness Group 
aSymptoms lasting for over 1 year. bGroup chronicity and relationship proportions did not differ 
significantly at the .05 level.   
 
 CD FSS MUS 
Participants 46 79 23 
 
Gender 
 
36 F, 10 M 
 
67 F, 11 M,                     
1 Not Answered 
 
16 F, 7 M 
 
Mean Age 
 
42.07 
(SD = 1.11) 
 
45.58 
(SD = 12.80) 
 
37.52 
(SD = 15.63) 
 
Illness Chronicityab 
 
80.43% 
 
95.0% 
 
66.3% 
 
Annual Income 
 
37.0% in $20,000 - 
$50,000 bracket 
 
33.0% in $20,000      
- $50,000 bracket 
 
39% in less than 
$20,000 bracket 
 
In a Relationshipb 
 
71.8% 
 
 
72.2% 
 
 
52.1% 
 
 
Race/Ethnicity 
 
87.0% 
White/Caucasian 
 
92.4% 
White/Caucasian 
 
95.7% 
White/Caucasian 
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Procedure 
 
 Recruitment. Participant recruitment was accomplished through in-person visits 
to health clinics in the Jacksonville area and through online postings to discussion boards 
of illness support groups. Brochures left at the clinics (per clinic permission) and the web 
recruitment notices (adhering to particular web community guidelines) contained 
information describing the VOICE study and directed interested participants to the online 
surveys. To ensure as representative a sample as possible, clinics of the medical 
spectrum, from primary care physicians and specialists to massage therapists and 
alternative healers, on all sides of town were visited. Online recruitment followed this 
same inclusive strategy. Recurrent postings were made on discussion boards for a wide 
variety of chronic physical conditions as well as those devoted to unexplained symptoms. 
At the time of analysis, 72 clinics had been visited and 42 websites/discussion boards had 
VOICE postings. Recruitment efforts succeeded in engaging the participation of 
hundreds of people (as many as 572 for one survey); however, attrition and other 
exclusionary factors resulted in the smaller, final data set.    
Measures.  While the four surveys encompassed multiple measures, only the ones 
relevant to this analysis will be discussed here. Of primary interest for this particular 
study were measures that assessed symptom experience, stress appraisal, perceived 
controllability and coping strategies. Additionally, measures that captured health-related 
factors that could be of impact, such as depression, anxiety and affect were also included.   
 Symptom experience and stress appraisal. Symptom experience was measured 
using the Revised Illness Representations Questionnaire (IPQ-R) with modifications to 
evaluate the severity of somatic symptoms (PHQ-15) and the treatment effects for 
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somatoform disorders (SOMS-7).  Revised from the Illness Perception Questionnaire 
developed by Weinman and colleagues (1996) to measure the five components of 
Leventhal’s self-regulatory model of illness representations (i.e., identity, consequences, 
timeline, control/cure and cause), the IPQ-R by Moss-Morris and colleagues (2002) 
expanded the widely adopted  IPQ to include additional subscales (Moss-Morris et al., 
2002). Factor analyses of both the IPQ and the IPQ-R indicated sound validity and 
reliability (Cronbach’s alphas for study items range from .80 to .84); thus, they were 
appropriate measures in determining patient perception of illness (Hagger & Orbell, 
2005; Moss-Morris et al., 2002).  
For the questions regarding symptom experience, participants were presented with 
a list of symptoms, like nausea, fatigue, breathlessness and sore throat, to which they 
responded yes or no to whether they have been bothered and just how bothered  (e.g. 
“bothered a little”, “bothered a lot”) by the symptom(s) during the past four weeks.  If 
they answered in the affirmative, a follow-up question was asked to determine if the 
particular symptom was believed to be related to their chronic condition. From these 
responses, scales for illness identity and illness severity were calculated. For the VOICE 
study, the IPQ-R was adapted to include symptom questions from the PHQ-15 and the 
SOMS-7 for a total of 63 symptoms explicitly assessed and one open-ended question to 
assess any other symptom(s) not included in the list. 
 Pain was assessed through the IPQ-R as well as through responses to specific pain 
questions from the SF-36 Health Survey Manual and Interpretation Guide (Ware, 
Kosinski, & Gandek, 2004). Participants responded to the SF-36 questions through 
selection of one of two (i.e., yes/no), three, five or six responses. For the pain questions, 
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participants rated their bodily pain by responding none, very mild, mild, moderate, severe 
or very severe to the question, “How much bodily pain have you had during the past 4 
weeks?” Participants rated interference by pain by responding “not at all, a little bit, 
moderately, quite a bit or extremely” to the question, “During the past 4 weeks, how 
much did pain interfere with your normal work (including both work outside the home 
and housework)?”  Internal consistency reliability estimates for the SF-36 scales are 
above .70, which are acceptable measures of reliability (Gandek, Sinclair, Kosinski, & 
Ware, 2004).  
To assess current levels of overall stress, participants were asked to rate their 
stress level on a 5-point scale (with 1 indicating “low stress” and 5 “high stress”). This 
measure, the Self-Rated Stress Score (SRSS), was shown to be positively correlated with 
psychological distress (Lim, Williams, & Hagen, 2005). The addition of the SF-36 and 
SRSS measures allowed a more composite picture to emerge of symptom appraisal and 
experience.  
Perceived controllability and consequences. IPQ-R items that formed the 
subscales of personal control, treatment control and consequences contained questions 
which included “There is a lot which I can do to control my symptoms” and “My illness 
is a serious condition”. Participants responded to each question on a 5-point Likert scale 
that ranged from strongly disagree, disagree, neither agree nor disagree, agree to 
strongly agree. The average score of the questions within each subscale was used to 
determine the extent to which a participant experienced the given construct (e.g. higher 
scores for personal control reflected a greater sense of mastery over illness).
Negative affect, depression and anxiety. Negative affect was measured using five  
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items from the International Positive and Negative Affect Schedule Short Form (I-
PANAS-SF) developed by E.R. Thompson (Thompson, 2007).  The I-PANAS-SF items 
used in the study were those that measured negative affect; a Cronbach’s alpha of .76 is 
estimated for this particular subscale (Thompson, 2007). Responses to these items were 
on a 6-point Likert scale from 0 (never) to 6 (always); participants were asked to rate how 
often they normally felt upset, hostile, ashamed, nervous and afraid. To assess 
depression, the Patient Health Questionnaire (PHQ-8) by Kroenke and colleagues was 
used (Kroenke et al., 2009). The PHQ-8 consists of eight items that assessed how 
frequently participants were bothered by problems that included “feeling down, 
depressed, or hopeless” and “trouble concentrating on things, such as reading the 
newspaper or watching television”. Responses were in the format of 4-point Likert scale 
that ranged from 0 (not at all) to 3 (nearly every day). To assess anxiety, the anxiety scale 
from the Hopkins Symptom Checklist (HSCL) developed by Derogatis and colleagues 
was used (Derogatis, Lipman, Rickels, Uhlenhuth, & Covi, 1974). The six items of the 
anxiety scale asked to what extent participants felt “nervousness or shakiness inside” and 
“suddenly scared for no reason” during the past 4 weeks; participants responded on a 4-
point Likert scale that ranged from 1 (not at all) to 4 (extremely). 
Coping strategies. Coping strategies were assessed using the Brief-COPE (1997), 
a 28-item measure adapted by Carver from the longer COPE protocol (Carver, 1997; 
Carver et al., 1989). The Brief-COPE consists of 14 subscales of two items each of 
various forms of coping: active coping, planning, positive reframing, acceptance, humor, 
religion, using emotional support, using instrumental support, self-distraction, denial, 
venting, substance use, behavioral disengagement and self-blame. Participants responded 
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on a 4-point Likert scale (from I haven’t been doing this at all to I’ve been doing this a 
lot) to 28 statements (e.g., “I’ve been taking action to try to make the situation better” and 
“I’ve been making jokes about it”) that made up the 14 coping dimensions. Like its 
predecessor, the Brief-COPE is regarded as a valid, reliable (subscale Cronbach’s alphas 
range from .50 to .90 with ten at .65 or greater) instrument; it is a widely used measure in 
many health-related studies (Carver, 1997; Muller & Spitz, 2003).  
Results 
 
 Statistical analyses were conducted, as appropriate for the item(s) being analyzed, 
using multivariate tests, correlational coefficients and linear regression. Alpha levels for 
all analyses were set at .05 and the nature of significant differences in groups was 
determined by Tukey’s HSD post-hoc tests. Levene’s test for equal variances was used to 
test the homogeneity of variances assumption; unless otherwise noted, Levene’s tests for 
the multivariate analyses were not significant (all ps > .05). Because of missing data for 
particular items, the number of participant responses for some items is less than the total 
participant count of 148.      
Symptom Experience and Stress Appraisal  
Multivariate analyses (MANOVAs) were run on the adapted IPQ-R items for 
symptoms and the SF-36 pain questions to determine if there were illness group 
differences in symptom experience. Significant differences by illness group were found, 
Wilks’s Lambda = .84, F(10, 272) = 2.40, p = .01, partial eta2 = .08. Results from the 
post-hoc tests determined that the FSS group reported significantly more symptoms, 
Wilks’s Lambda = .84, F(2, 140) = 3.74, p = .03, partial eta2 = .05, and amount of   
symptoms bothered by, Wilks’s Lambda = .84, F(2, 140) = 3.81, p = .02, partial eta2 = 
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.05, when compared to the MUS group; no such differences existed between the FSS and 
CD groups nor the MUS and CD groups. The groups showed no significant differences in 
illness identity (number of symptoms believed to be related to illness) or illness severity 
(number of symptoms bothered by that are believed to be related to illness). However, 
significant group differences were found in pain perception, Wilks’s Lambda = .84, F(2, 
140) = 7.03, p < .001, partial eta2 = .10. Post-hoc tests revealed that the FSS group 
reported significantly higher levels of pain (M = 8.17, SD = 2.02) than both the CD (M = 
7.02, SD = 2.58) and MUS (M = 6.14, SD = 2.61) groups; no significant differences in 
pain ratings existed between the CD and MUS groups. In terms of overall stress (SRSS), 
illness groups showed no significant differences, Wilks’s Lambda = .84, F(2, 140) = 
1.12, p = .33.  
Because of the significant differences by pain, the groups were split by their 
bodily pain severity (e.g., CD and CD with severe pain) to see if differences would 
emerge along this dimension. Even when these groups were further subdivided by pain, 
they showed no significant differences in symptoms bothered by, illness identity, illness 
severity nor overall stress: for illness groups with moderate to severe pain, Wilks’s 
Lambda = 0.84, F(2, 59) = 1.00, p = .45 and for illness groups with none/little to mild 
pain, Wilks’s Lambda = 0.87, F(2, 77) = 1.07, p = .39. When illness group delineation 
was not taken into account and responses were compared strictly by pain severity, there 
were significant differences, Wilks’s Lambda = 0.73, F(1, 140) = 10.16, p < .001, partial 
eta2 = 0.27. Participants with more severe pain, irrespective of illness group, reported 
significantly higher levels of symptoms, symptom distress and overall stress than those 
with little to mild pain. The partial eta2 indicates that pain severity accounted for 27% of 
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the differences in these two groups (including error variance). See Table 5 for more 
details.          
Table 5. Mean Symptom Experience by Pain Severity 
Items None/Little to Mild Pain (N = 84) 
Moderate to Severe Pain 
(N  = 62) 
Symptom Count** 23.25 (SD = 11.62) 35.03 (SD = 11.44) 
Symptoms Bothered By** 32.25 (SD = 18.29) 54.13 (SD = 19.95) 
Illness Identity ** 16.29 (SD = 11.04) 28.66 (SD = 14.27) 
Illness Severity** 23.44 (SD = 17.85) 44.13 (SD = 22.35) 
Self-Rated Stress Score*         3.24 (SD = 1.11) 3.68 (SD = 1.25) 
Note. Levene’s test of equality of error variances was significant (p < .05) for both illness identity 
and illness severity.                                                       
* Difference significant at the .05 level. ** Difference significant at the .01 level.  
 
 
Perceived Controllability and Consequences 
 
Multivariate analyses (MANOVAs) were conducted on the IPQ-R subscales of 
consequences, personal control and treatment control. Significant illness group 
differences were found for consequences and treatment control, Wilks’s Lambda = .79, 
F(2, 142) = 5.69, p < .001, partial eta2 = .11. It is important to note that for these 
analyses, Levene’s test indicated significant differences in error variances, p < .001 for 
both subscales. With this in mind, the results showed that the MUS group (M = 3.38, SD 
= 1.28) exhibited significantly lower perceived consequences than both FSS (M = 4.34, 
SD = 0.62) and CD (M = 4.12, SD = 0.76). Regarding treatment control, the only 
significant difference was between FSS (M = 2.37, SD = 0.93) and CD (M = 2.85, SD = 
0.92); this difference suggests that the CD group reports a greater sense of control 
concerning illness treatment.   
Negative Affect, Depression and Anxiety 
 
Multivariate analyses (MANOVAs) testing illness group differences in negative
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 affect, depression and anxiety revealed only significant group differences in depression, 
Wilks’s Lambda = .86, F(2, 145) = 10.28, p < .001, partial eta2 = .12. Post-hoc tests 
indicated significantly higher levels of depression in the FSS group (M = 20.89, SD = 
5.72) than the CD (M = 18.26, SD = 6.13) and MUS (M = 14.83, SD = 5.74) groups.
The CD and MUS groups did not significantly differ from one another in any of these 
tests. For a comparison of illness groups by all these items, see Table 6. 
    Table 6. Illness Group Means Across Items 
Item CD FSS MUS 
Symptom Count  27.18 (SD = 12.85)   30.57*(SD = 12.16)  22.45  (SD = 14.16) 
Bothereda  39.61 (SD = 20.30)   45.60*(SD = 21.44)  31.82  (SD = 23.73) 
Illness Identity  20.80 (SD = 13.73)   23.12  (SD = 14.13)  17.91  (SD = 13.40) 
Illness Severity  30.93 (SD = 21.51)   34.78  (SD = 22.55)  26.68  (SD = 23.00) 
Pain   7.02 (SD = 2.58)    8.17*(SD = 2.02)    6.14  (SD = 2.61) 
Stress Level   3.43 (SD = 1.18)    3.52  (SD = 1.21)    3.09  (SD = 1.11) 
Consequences   4.12 (SD = 0.76)    4.34  (SD = 0.62)    3.38*(SD = 1.28) 
Pers. Controlb   3.07 (SD = 0.90)    3.02  (SD = 1.09)    2.81   (SD = 1.32) 
Treat.Controlc   2.85 (SD = 0.92)    2.37* (SD = 0.93)    2.52   (SD = 1.45) 
Negative Affect 14.74 (SD = 7.02) 16.29  (SD = 6.58)  13.35  (SD = 6.26) 
Depression 18.26 (SD = 6.13) 20.89*(SD = 5.72)  14.83  (SD = 5.74) 
Anxiety 10.26 (SD = 3.96) 10.90  (SD = 3.84)    8.74  (SD = 3.51) 
       aBothered is symptoms bothered by. bPersonal Control, cTreatment Control.   
    * Mean difference significant at the .05 level 
 
Coping Strategies  
 
Each coping subscale from the Brief-COPE was analyzed for illness group 
differences. A MANOVA revealed no significant differences in coping strategies by 
illness groups, Wilks’s Lambda = .71, F(2, 122) = 1.45, p = .08. Coping strategies were 
also assessed to see if they varied by whether they were active or passive/avoidant. To 
accomplish this, strategies were grouped into the categories of active or passive/avoidant 
based on recommendations in the literature (Carver et al., 1989), which were further 
supported by evidence that logically related strategies were positively correlated 
(examples of strategies that were significantly correlated at the .01 level include active 
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coping and planning r(140) = .77; using emotional support and using instrumental 
support, r(141) = .51; self-blame and denial, r(140) = .33; denial and behavioral 
disengagement, r(137) = .32). Two subscales, humor and religion, were excluded from 
the active and passive/avoidant groups. These two subscales were excluded because they 
were significantly correlated with both active and passive/avoidant coping style. This was 
not an unexpected finding as Carver and colleagues (1989) remarked that the 
multifaceted uses of humor and religion can manifest as seemingly contradictory forms of 
coping (i.e., humor can be a form of instrumental coping as well as a form of venting; 
Carver et al., 1989). Table 7 illustrates the grouping of the coping subscales. 
 
Table 7. Grouped Coping Strategies into Coping Styles 
Active Passive/Avoidant 
Active Coping Self-Distraction 
Using Instrumental Support Behavioral Disengagement 
Using Emotional Support Venting 
Planning Substance Use 
Positive Reframing Self-Blame 
Acceptance Denial 
Note. The two scales were created by summing the relevant subscales. Pearson’s correlation coefficient 
indicated that the two styles were not significantly correlated, r(124) = .10, p = .28.  
 
 
 
Following the creation of the coping style groups, multivariate analyses 
(MANOVAs) were conducted to determine if coping styles varied by illness group. The 
results showed no significant differences in coping styles by illness groups, Wilks’s 
Lambda = .96, F(4, 244) = 1.25, p = .29.  
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 Pearson’s correlation coefficients (r) were calculated to assess the degree of co-
relationships among items measuring symptom experience, personal controllability, 
negative affect, depression, anxiety, stress, pain and coping styles. Because the four IPQ-
R items of symptom experience (i.e., count, bothered by, identity and severity) were 
highly and significantly intercorrelated (ranging from r of .82 to .96), they were summed 
to create a new scale variable (“Symptoms”) so as to simplify analysis.  For personal 
controllability, significant correlations were found between that item and active coping, 
r(131) = .17; anxiety, r(145) = -.19; depression, r(145) = -.23 and symptoms, r(140) = -
.17; all correlations for that item were significant at the .05 level, except depression 
which was significant at the .01 level.  Significant results for the remainder of the items 
are summarized in Table 8.  
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Table 8. Significant Correlations Among Items  
 Negative 
Affect 
Depression Anxiety Stress Pain P/Ac Coping 
Neg. Affect -- .66** .71** .56** .36** .56** 
Depression .66** -- .64** .39** .58** .48** 
Anxiety .71** .64** -- .41** .36** .49** 
Stressa .56** .39** .41** -- .21** .34** 
Pain .36** .58** .36** .21** -- .34** 
Symptomsb .30** .48** .46** .16* .58** .31** 
 aStress was negatively correlated with active coping, r(132) = -.21, p = .02.  
 bSymptoms was positively correlated with active coping, r(128) = .21, p = .02. 
 cPassive/Avoidant.  
*Correlation is significant at the .05 level.  
**Unless otherwise noted, all correlations significant at the .01 level. 
 
 
 As tests continued to show that the factors of negative affect, depression, anxiety, 
stress, pain, symptom experience and personal control showed significant relationships 
with coping styles (particularly passive/avoidant coping), a MANCOVA was conducted 
to see if coping styles differed by illness groups when the significant factors were 
included as covariates. Even while controlling for the significant covariates, there was no 
indication of any significant differences in coping styles by illness group, Wilks’s 
Lambda = .96, F(4, 222) = 1.05, p = .38. 
Exploratory Analyses 
 To explore the relationships between the aforementioned significant factors and 
coping styles, multiple linear regressions were conducted to see if coping styles could be 
predicted by those factors. Both regressions proved to be significant for this predictive 
model: for active coping, R2= .16, F(7,121) = 3.34, p = .003 and for passive/avoidant 
coping, R2= .35, F(7,122) = 9.45, p < .001. Multicollinearity tests for both showed no 
tolerance values of less than .05, indicating no problems with multicollinearity.  For both 
models, the seven factors explained a significant proportion of variance in coping styles. 
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The results indicated that stress, β = -.21, t(120) = -2.09, p = .04;  symptoms, β = .32, 
t(120) = 2.82, p = .01; and personal control, β = .19, t(120) = 2.16, p = .03, significantly 
predicted active coping strategies; negative affect significantly predicted passive/avoidant 
coping strategies, β = .34, t(121) = 2.81, p = .01. Table 9 provides more details on the 
regression predictors.   
Table 9. Regression Predictors for Coping Styles 
 Active (N = 128) Passive/Avoidant (N = 129) 
Predictors β t p β t p 
Negative Affect .05 0.38 .71 .34 2.81    .01* 
Depression -.20 -1.49 .14 .13 1.09 .28 
Anxiety .01 0.06 .95 .10 0.88 .38 
Stress -.21 -2.09   .04* .04 0.41 .69 
Pain .05 0.45 .66 .06 0.61 .55 
Symptoms .32 2.82   .01* .05 0.51 .61 
Personal Control .19 2.16   .03* -.02   -0.31 .76 
  *Predictor is significant at the .05 level 
 
Discussion 
 
 Tests of the hypotheses. The results of this study revealed that coping strategies 
did not differ by illness group, but as expected, it was the mechanisms of appraisal that 
contributed to coping variation. Coping style was predicted by health-related factors that 
influence appraisal; in particular, stress, symptoms and personal control were significant 
contributors for active coping prediction, whereas negative affect was significant for 
passive/avoidant coping. It was interesting to see that while illness groups largely 
associated with stress, symptom appraisals and negative affect (i.e., FSS and MUS) did 
not exhibit relationships with any specific coping strategies, it was these defining 
characteristics of FSS and MUS that did. 
 The findings on negative affect reflect that of previous research, such as that of 
Kraaij and associates (2009) who found that the passive/avoidant coping strategies of 
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self-blame and disengagement were significant in their regression model for negative 
affect as well as findings by Theadom and Humphrey (2007) that negative affect was 
significantly and inversely correlated with active coping and positive reinterpretation in 
patients with fibromyalgia (Kraaij, Garnefski, & Schroevers, 2009; Theadom & 
Humphrey, 2007). When Ben-Zur (2009) examined coping-affect relationships in 
adolescents, undergraduate students and a sample of the general community, she found 
that avoidance coping showed a positive association with negative affect, β = .31, p < 
.001, and a negative association with positive affect, β = -.24, p < .001 (Ben-Zur, 2009). 
Her results suggest that while directionality of the avoidant coping-negative affect 
relationship is ambiguous, the two may mutually reinforce one another (Ben-Zur, 2009). 
Negative affect embodies sensitivity to aversive cues, like symptoms and stress. Those 
with negative affect may have greater difficulty in using active coping strategies, 
resulting in more frequent use of passive/avoidant coping strategies that, by definition, do 
not directly address stressors or involve conscious regulation of the emotional responses 
to stress. Through passive/avoidant coping, the stressors themselves are not changed or 
mitigated; a person with greater proclivity toward negative appraisals may keep assessing 
and avoiding the aversive cues, maintaining this avoidant coping-negative affect 
relationship, which is associated with poorer outcomes (Ben-Zur, 2009; Felton & 
Revenson, 1984).      
 As for active coping, levels of personal control predicted this dimension of 
coping, which is consistent with the idea that those that believe they can control health 
outcomes will be engaged in action-oriented strategies to cope with illness. A more 
counterintuitive finding in the regression model was of symptoms and active coping. It 
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would seem that with increased symptoms and presumably, increased levels of 
discomfort, distress, impairment and functional limitations, the predicted coping 
strategies would be passive/avoidant, as opposed to active. An explanation for this may 
be that as a result of their long duration of illness experiences, participants have learned 
how to accommodate for their symptoms. Brown and colleagues (2010) suggest that 
when living with chronic illness over a long period of time, coping skills improve from 
what they were in the early stages (Brown, M., Brown, A., & Jason, 2010). As 
participants of this study report long illness duration (85.8% for over one year), perhaps 
they have adapted to their conditions and are in a position to be able to actively manage 
symptoms.  
 Though the data do not support coping differences by illness types, the FSS group 
did report greater pain and symptom experience than the other groups, data consistent 
with the stress system dysregulation theory. Also consistent is the notion that for there to 
be greater appraisal and symptom perceptual differences, there should be greater 
differentiation in stress. For this study, the mean levels of stress were in the moderate 
range (from 3.09 for MUS to 3.52 for FSS) and did not significantly differ per group; the 
stress similarity could help explain why the groups showed few differences in appraisal 
and none in coping. The results of this study support other findings on stress system 
dysfunction and coping: a significant, positive correlation between passive/avoidant 
coping style and stress (Chrousos, 2009; Hori et al., 2010). Furthermore, in the regression 
model, higher ratings of stress predicted less use of active coping strategies. Stress 
sensitivities and disorders are not limited to any particular illnesses or illness groups, 
even if FSS and MUS are associated with stress dysregulation. These findings illustrate 
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that the relationship between stress and coping is not mediated by a type of illness, even 
if the illness is associated with appraisal sensitivity. It is the individual, subjective 
experience of stress that predicts coping.  
 In terms of illness experience and related factors, the MUS group was expected to 
behave similarly to the FSS group. However, analyses showed that the MUS group was 
an entity all its own in terms of lower perceived consequences, lower counts of symptoms 
and symptom severity, as well as lower levels of stress, pain, depression, anxiety and 
negative affect. Though these means were not significantly lower than that of the FSS 
and CD groups (except that of consequences), the quantitative differences suggest that 
having medically unexplained symptoms may be a qualitatively different experience than 
having a functional somatic syndrome or conventional disease.  
 The reliability and validity of these data are corroborated by the results of other 
studies. Approximating this study’s FSS group (N = 79), the sample for a study that 
investigated sensory amplification in 38 patients with fibromyalgia and/or chronic fatigue 
syndrome consisted of primarily women (73.6%) with a mean age of 42.0 (SD = 8.8) that 
reported pain for over one year and an average amount of 19.2 (SD = 9.7) physical 
symptoms (Geisser et al., 2008). The scales of physical symptoms differed (51 items for 
the Geisser study and 63 for this study), but both studies yielded a substantial amount of 
physical symptoms for analogous participants (Geisser et al., 2008). In a study of 206 
patients with MUS considered to be high-utilizers of primary care (an average of 13.6 
visits the year prior to the study), the psychosomatic symptom mean was 23.0 (SD = 
15.2); in comparison, the mean symptom count for MUS in this study was nearly 
identical at 22.5 (SD = 14.2) (Smith et al., 2005). The typicality of this sample and these 
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results provide further evidence for the relationship between FSS/MUS and appraisal  
sensitivity.     
 The sample. It is important to consider the participants of this study and sample 
characteristics that may have influenced the results. The sample was 80% female; since 
the participants were mainly women, any gender differences would be difficult to find. 
The significant predictors for coping style were factors that some studies have shown are 
more associated with women. For example, in a Canadian study of 131,535 individuals, 
with an equal proportion of men and women and a mean age of 42.1 years, 38.4% of 
women versus 27.1% of men reported at least one chronic pain condition (i.e., 
fibromyalgia, arthritis/rheumatism, back problems and/or migraine headaches); excluding 
back problems, all the conditions were more prevalent in women and women reported 
depression at twice the rate of men (Munce & Stewart, 2007). It is hard to tease apart 
effects by illness group if effects are largely associated with confounds like gender and 
the patient profile is typically female.  
 Another thing to consider is that the sample participants may be somewhat 
different from the greater population of those with chronic illnesses. Perhaps these 
participants were more willing to communicate their illness experiences or uniquely 
persistent; perhaps these participants possessed characteristics that aligned more with the 
active coping style, which would thwart expected illness differentiation in coping. Survey 
attrition excluded the use of respondent data that may have provided more comprehensive 
understanding.  
 Limitations. There were some limitations to this study. The surveys were online 
instruments, so internet access was essential for participation. The surveys were also 
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quite lengthy, so attrition was somewhat unavoidable. Attrition was a major problem and 
even follow-up communication with consenting respondents did not necessarily secure 
participation.   
Though illness group assignment was done through careful consideration of 
available diagnostic information, many of these illnesses have fuzzy epidemiological 
boundaries. For example, depending on the source, fibromyalgia can belong to FSS or 
MUS or CD; most current research supports it as a functional somatic syndrome, which is 
why it is categorized as such (Barsky & Borus, 1999; Sharpe & Carson, 2001; Yunus, 
2007). Analyses may have been impacted by group assignment; examination of the 
experiences of the illnesses separately would be an excellent future avenue of research. 
These limitations do not eclipse the study’s strengths: the surveys’ multiple 
measures, including those not featured in this study (e.g., relationships and other 
supports, stigma, emotional representations, the use of complementary and alternative 
health treatments, causal attributions); the wealth of information provided by the 
participants that completed all four surveys; the diversity of illness and symptom 
experiences that were recruited through online postings, which may not have been 
possible solely through clinic recruitment in northeast Florida; the online nature of the 
surveys, which is appropriate and convenient as the internet penetrates everyday life 
(266.2 million people in North America alone use the internet; Internet World Stats, 
2010). The greatest success of this study was that it recruited so many participants of a 
demographic that is not easily accessible. While improvements could be made for future 
applications of the study, such as incentives to reduce attrition, additions of measures and 
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translation into other languages to capture non-English speakers, that the study 
elicited such a sizeable sample is quite an achievement.  
Future directions. Other future directions of research include analyses of chronic 
illnesses by pain perception; analyses exploring the connection between negative affect 
and passive/avoidant coping; coping comparisons that include healthy controls along with 
the illness groups; and differences in symptom scanning or hypervigilance across chronic 
illnesses. Table 5 provides a glimpse of the impact of pain perception and the group 
differences in pain expression; a study that focused on examining pain would be a natural 
follow-up to this study. Another natural follow-up, similar to the suggestion of 
exploration by illnesses, would be further investigation into the functional somatic 
syndromes. The FSS illnesses, while sharing diagnostic criteria, exhibited within-group 
heterogeneity that most likely affected group analyses (see Table 10). 
 
 
Table 10. Mean Comparisons of Top 3 Diagnoses of FSS Group  
 Depression Anxiety Pain P/Ac Coping 
 
Fibromyalgia 
 
22.48 
(SD = 5.78) 
 
11.35 
(SD = 4.14) 
 
9.23* 
(SD = 1.28) 
 
10.16 
(SD = 4.04) 
 
CFSa 17.82 
(SD = 2.48) 
8.91 
(SD = 1.87) 
7.73 
(SD = 1.68) 
7.91 
(SD = 2.77) 
 
RLSb 18.50 
(SD = 7.07) 
9.75 
(SD = 3.92) 
6.50 
(SD = 2.73) 
7.50 
(SD = 6.87) 
 
FSS Remaining 20.53 
(SD = 6.91) 
12.47 
(SD = 4.26) 
6.93 
(SD = 2.89) 
10.80 
(SD = 6.29) 
 
TOTAL 20.75 
(SD = 6.01) 
11.00 
(SD = 3.97) 
8.11 
(SD = 2.27) 
9.60 
(SD = 4.92) 
aCFS is Chronic Fatigue Syndrome. bRLS is Restless Legs Syndrome. 
cPassive/Avoidant * Mean difference significant at the .05 level.    
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Overall, the results from this study suggest that coping style may be a function of 
how respondents experience their illnesses or unexplained symptoms, irrespective of the 
actual illness or illness type. Since responses to certain items (i.e., personal control, 
stress, symptoms and negative affect) were strong indices for coping style, the knowledge 
that a patient may be more prone to maladaptive coping behaviors would be a valuable 
tool in determining what treatment interventions to introduce and support. Such screening 
could yield better health outcomes; even brief, self-administered questionnaires of 
depression, anxiety and somatoform disorders can be helpful in quickly assessing health-
relevant information, particularly for those patients in primary care with persistent 
symptoms that do not respond to standard treatments (Kroenke, Spitzer, Williams, & 
Löwe, 2010).  Instead of an emphasis on diagnosis to determine prognosis and 
treatments, assessing the whole patient and his/her particular experience with illness, 
which includes appraisal, controllability, outcome beliefs and methods of coping, appears 
to be a more effective approach that responds to the individual needs of the illness 
sufferer. Identifying and addressing how those with illness cope can facilitate wellness.  
Ensuring that they are equipped with the strategies and support to cope empowers them to 
take a proactive role in managing life with illness.  
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